Healthcare -
Biotechnology - NASDAQ - US
$ 1.98
-1.01 %
$ 147 M
Market Cap
-3.38
P/E
IKT - CASH FROM OPERATIONS
Cash from Operations IKT - Inhibikase Therapeutics, Inc.
-19.1 M
LAST VALUE
-5.05%
2 YEAR CAGR
-124.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR